Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Free Subscription
1 Acta Radiol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Does volumetric measurement of ADC values achieve higher diagnostic performance
in bladder cancer MRI?
Acta Radiol. 2024 Apr 9:2841851241241055. doi: 10.1177/02841851241241055.
PubMed
Abstract available
Updates on Urinary Bladder Tumors With Neuroendocrine Features.
Adv Anat Pathol. 2024;31:169-177.
PubMed
Abstract available
Predictors of Toxicity in a Randomized Study of Consolidation Chemoradiation
Versus Observation After First Line Chemotherapy in Advanced Gall Bladder
Cancers.
Adv Radiat Oncol. 2024;9:101468.
PubMed
Abstract available
Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics
of disulfidptosis and a prognostic signature in BLCA.
Aging (Albany NY). 2024;16:5751-5771.
PubMed
Abstract available
Immunotherapeutic value of NUSAP1 associated with bladder cancer through a
comprehensive analysis of 33 human cancer cases.
Am J Cancer Res. 2024;14:959-978.
PubMed
Abstract available
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients
with metastatic urothelial carcinoma progressing after platinum-based
chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Ann Oncol. 2024;35:392-401.
PubMed
Abstract available
Letter to the Editor for the Article "Prognostic Impact of Preoperative
Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract
Urothelial Carcinoma".
Ann Surg Oncol. 2024;31:3563-3564.
PubMed
Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative
Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract
Urothelial Carcinoma," by Urabe, Fumihik et al.
Ann Surg Oncol. 2024;31:3565-3566.
PubMed
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral
Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective
Observational Study.
Ann Surg Oncol. 2024 Apr 11. doi: 10.1245/s10434-024-15248.
PubMed
The Prognostic Value of the Combination of the Prognostic Nutritional Index and
the Lymphocyte:Monocyte Ratio for the Prediction of Patients with Muscle-Invasive
Bladder Cancer.
Arch Esp Urol. 2024;77:164-172.
PubMed
Abstract available
Analysis of the Clinicopathological Characteristics and Prognosis of Patients
with Nonurothelial Bladder Cancer.
Arch Esp Urol. 2024;77:148-157.
PubMed
Abstract available
Jolkinolide B synergistically potentiates the antitumor activity of GPX4
inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
Biochem Pharmacol. 2024;223:116194.
PubMed
Abstract available
Implementation of The Paris System for Reporting Urine Cytology improves
diagnostic accuracy of selective upper urinary tract cytology.
Cancer Cytopathol. 2024;132:242-249.
PubMed
Abstract available
MRI evaluation of vesical imaging reporting and data system for bladder cancer
after neoadjuvant chemotherapy.
Cancer Imaging. 2024;24:49.
PubMed
Abstract available
Autophagy flux in bladder cancer: Cell death crosstalk, drug and
nanotherapetuics.
Cancer Lett. 2024 Apr 7:216867. doi: 10.1016/j.canlet.2024.216867.
PubMed
Abstract available
Theories behind Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive
bladder cancer and update on current management.
Cancer Pathog Ther. 2023;2:74-80.
PubMed
Abstract available
CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer
through nonhomologous end-joining pathway.
Cell Signal. 2024 Apr 5:111164. doi: 10.1016/j.cellsig.2024.111164.
PubMed
Abstract available
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder
Cancer.
Cells. 2024;13:627.
PubMed
Abstract available
Potential-resolved electrochemiluminescence for simultaneous determination of
multiplex bladder cancer markers.
Chem Commun (Camb). 2024 Apr 8. doi: 10.1039/d4cc00996.
PubMed
Abstract available
Efficacy of immune checkpoint inhibitors combinations as first-line systemic
treatment in patients with advanced urothelial carcinoma: A systematic review and
network meta-analysis.
Crit Rev Oncol Hematol. 2024;196:104321.
PubMed
Abstract available
The association between paraneoplastic neurological syndromes (PNS) and
urothelial carcinoma - A review of the literature.
Crit Rev Oncol Hematol. 2024;196:104314.
PubMed
Abstract available
Molecular research in bladder cancer.
Curr Opin Urol. 2024 Apr 12. doi: 10.1097/MOU.0000000000001181.
PubMed
Advances in preclinical assessment of therapeutic targets for bladder cancer
precision medicine.
Curr Opin Urol. 2024 Apr 11. doi: 10.1097/MOU.0000000000001177.
PubMed
Abstract available
Is there a role for metastasis-directed therapy in bladder cancer?
Curr Opin Urol. 2024 Apr 5. doi: 10.1097/MOU.0000000000001174.
PubMed
Abstract available
Advances in tumor microenvironment and underlying molecular mechanisms of bladder
cancer: a systematic review.
Discov Oncol. 2024;15:111.
PubMed
Abstract available
Integrative analysis of the bladder cancer from a cell cycle NCAM1 perspective at
both single cell and bulk resolution.
Environ Toxicol. 2024 Apr 6. doi: 10.1002/tox.24260.
PubMed
Abstract available
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Apr 9:S0302-2838(24)02262-0. doi: 10.1016/j.eururo.2024.
PubMed
Front-line Platinum Continues To Have a Role in Advanced Bladder Cancer.
Eur Urol Focus. 2024 Apr 5:S2405-4569(24)00049-X. doi: 10.1016/j.euf.2024.
PubMed
Abstract available
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing
Intravesical System (TAR-200) in American Urological Association-defined
Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
Eur Urol Open Sci. 2024;62:8-15.
PubMed
Abstract available
A meta-analysis of UCA1 accuracy in the detection of bladder cancer.
Expert Rev Anticancer Ther. 2024 Apr 12. doi: 10.1080/14737140.2024.2342528.
PubMed
Abstract available
Editorial: Biomarkers and immunotherapy for genitourinary tumors.
Front Immunol. 2024;15:1394170.
PubMed
Effectiveness of adjuvant chemotherapy for patients who undergo radical
cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115
advanced bladder cancer patients with pathological lymph node classification.
Int J Urol. 2024 Apr 12. doi: 10.1111/iju.15465.
PubMed
Abstract available
Comparison of morbidity and mortality after radical cystectomy between
individuals older and younger than 80 years: a systematic review and
meta-analysis.
Int Urol Nephrol. 2024;56:1525-1535.
PubMed
Abstract available
Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with
Bladder Cancer and Their Clinical Implications.
Iran J Immunol. 2024;21.
PubMed
Abstract available
Comparison of the efficacy of enfortumab vedotin between patients with metastatic
urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world
data from a multi-institutional study in Japan.
J Cancer Res Clin Oncol. 2024;150:182.
PubMed
Abstract available
Impact of concurrent medications on clinical outcomes of cancer patients treated
with immune checkpoint inhibitors: analysis of Health Insurance Review and
Assessment data.
J Cancer Res Clin Oncol. 2024;150:186.
PubMed
Abstract available
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential
target for therapy with enfortumab vedotin.
J Cutan Pathol. 2024 Jan 10. doi: 10.1111/cup.14579.
PubMed
Abstract available
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B) in patients with
BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the
tumor microenvironment.
J Exp Clin Cancer Res. 2024;43:109.
PubMed
Abstract available
Type III interferon inhibits bladder cancer progression by reprogramming
macrophage-mediated phagocytosis and orchestrating effective immune responses.
J Immunother Cancer. 2024;12:e007808.
PubMed
Abstract available
Platinum ineligibility and survival outcomes in patients with advanced urothelial
carcinoma receiving first-line treatment.
J Natl Cancer Inst. 2024;116:547-554.
PubMed
Abstract available
Challenges and technical aspects in the management of muscle invasive bladder
cancer as retrograde radical cystectomy with ileal conduit.
J Pak Med Assoc. 2024;74:513-518.
PubMed
Abstract available
Paraganglioma of the urinary bladder: A case report.
J Pak Med Assoc. 2024;74:570-572.
PubMed
Abstract available
Fish: A Promising Screening Tool for Malignancy After Augmentation Cystoplasty?
J Pediatr Surg. 2024;59:725-730.
PubMed
Abstract available
Assessment of interleukin 17A and 23 in the course of bladder cancer and selected
benign urological diseases.
J Physiol Pharmacol. 2024;75.
PubMed
Abstract available
Near-infrared fluorescence lymph node template region dissection plus backup
lymphadenectomy in open radical cystectomy for bladder cancer using an innovative
handheld device: A single center experience.
J Surg Oncol. 2024 Apr 7. doi: 10.1002/jso.27618.
PubMed
Abstract available
Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health Related
Quality of Life Measures: An Assessment of the Comparative Effectiveness of
Survivorship Health in Bladder Cancer (CEASE-BC) Study.
J Urol. 2024 Apr 11:101097JU0000000000003964. doi: 10.1097/JU.0000000000003964.
PubMed
Abstract available
"Internet Plus" continuous nursing for patients with advanced bladder cancer: A
retrospective observational study.
Medicine (Baltimore). 2024;103:e37822.
PubMed
Abstract available
[Retracted] Propofol modulates the proliferation, invasion and migration of
bladder cancer cells through the miR?145?5p/TOP2A axis.
Mol Med Rep. 2024;29:94.
PubMed
Abstract available
Modifying Effects of Genetic Variations on the Association Between Dietary
Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the
Be-Well Study.
Mol Nutr Food Res. 2024 Apr 6:e2400087. doi: 10.1002/mnfr.202400087.
PubMed
Abstract available
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data
System.
Nat Rev Urol. 2024;21:243-251.
PubMed
Abstract available
Experimental and New Approaches for Bladder Preservation in Intermediate and
High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC).
Res Rep Urol. 2024;16:89-113.
PubMed
Abstract available
Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and
challenging feature. A case report.
Rev Esp Patol. 2024;57:116-119.
PubMed
Abstract available
Optimal timing for the first cystoscopic follow-up using time-to-treatment
initiation analysis of oncologic outcomes in primary non-muscle invasive bladder
cancer.
Sci Rep. 2024;14:8440.
PubMed
Abstract available
A study on the significance of serine hydroxymethyl transferase expression and
its role in bladder cancer.
Sci Rep. 2024;14:8324.
PubMed
Abstract available
A chromosome-scale fishing cat reference genome for the evaluation of potential
germline risk variants.
Sci Rep. 2024;14:8073.
PubMed
Abstract available
Clinical performance and utility of a noninvasive urine-based methylation
biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Sci Rep. 2024;14:7941.
PubMed
Abstract available
Disease progression in Bacillus Calmette Guerin unresponsive non-muscle invasive
bladder cancer patients with carcinoma in situ, participating in clinical trials
on bladder-sparing treatment.
Transl Androl Urol. 2024;13:479-482.
PubMed
Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for
muscle-invasive bladder cancer: conclusions from SWOG S1314.
Transl Androl Urol. 2024;13:458-462.
PubMed
Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The
Urinary Bladder: Based on The SEER Database.
Urol J. 2024;21:87-97.
PubMed
Abstract available
Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve
Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
Urol J. 2024;21:107-113.
PubMed
Abstract available
Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for
urinary bladder cancer diagnosis and classification.
Urol Oncol. 2024 Apr 8:S1078-1439(24)00361-2. doi: 10.1016/j.urolonc.2024.
PubMed
Abstract available
Evaluation of histological variants of upper tract urothelial carcinoma as
prognostic factor after radical nephroureterectomy.
World J Urol. 2024;42:225.
PubMed
Abstract available
Development and validation of a clinical and ultrasound features-based nomogram
for preoperative differentiation of renal urothelial carcinoma and central renal
cell carcinoma.
World J Urol. 2024;42:227.
PubMed
Abstract available
Perioperative complications and oncological outcomes of open versus
robotic-assisted radical cystectomy: a propensity score-matched study.
World J Urol. 2024;42:220.
PubMed
Abstract available
Thank you for your interest in scientific medicine.